Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02735083 · ClinicalTrials.gov registry record · Phase 1
A Study to Evaluate the Long-term Safety of Patients With Advanced Lymphoid Leukemia Who Have Been Previously Administered With UCART19
A Phase 1 study of Advanced Lymphoid Leukemia, sponsored by Institut de Recherches Internationales Servier.
- Active
- Registry status
- Phase 1
- Development phase
- 28
- Enrollment target
- 16
- Study locations
NCT02735083 is a Phase 1 study of Advanced Lymphoid Leukemia that is active but no longer recruiting, run by Institut de Recherches Internationales Servier. The registered enrollment target is 28 participants. The trial reports 16 study locations across 7 states.
The verdict
NCT02735083, a Phase 1 study of Advanced Lymphoid Leukemia, is active but no longer recruiting, sponsored by Institut de Recherches Internationales Servier.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 28 participants
- Enrollment target
- 16
- Study locations
Study Summary
The purpose of this study is to evaluate the long-term safety and efficacy of UCART19 administration to patients with advanced lymphoid leukemia.
Conditions Studied
Interventions
- BIOLOGICAL UCART19 follow-up
Study Locations (16)
Other
- Hôpital Saint-Louis - Paris
- Hôpital Robert-Debré - Paris
- Hôpital Saint-Antoine - Paris
- Kyushyu University Hospital - Fukuoka
- Hokkaido University Hospital - Sapporo
- Hospital San Juan De Dios - Barcelona
- King's College Hospital NHS Foundation Trust - London
- UCL Great Ormond Hospital - London
- The Christie NHS Foundation Trust - Manchester
Texas
- University of Texas Southwestern Medical Center - Dallas
- University of Texas MD Anderson Cancer Center - Houston
California
- Children's Hospital Los Angeles - Los Angeles
Colorado
- Colorado Blood Cancer Institute - Denver
Florida
- Moffit Cancer Center - Tampa
Massachusetts
- Massachussetts General Hospital - Charlestown
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2021-03-10 |
| Est. Completion | 2028-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02735083
The ClinicalTrials.gov registry entry for NCT02735083 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Institut de Recherches Internationales Servier, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Advanced Lymphoid Leukemia appearing as the primary indexed condition, and to 1 intervention - of which UCART19 follow-up is the first listed.
NCT02735083 reports 16 study locations spanning 7 distinct geographic areas - top geographies include Other, Texas, California.
Frequently Asked Questions
What is clinical trial NCT02735083 about?
NCT02735083 is a clinical study titled "A Study to Evaluate the Long-term Safety of Patients With Advanced Lymphoid Leukemia Who Have Been Previously Administered With UCART19". The purpose of this study is to evaluate the long-term safety and efficacy of UCART19 administration to patients with advanced lymphoid leukemia.
What is the current status of trial NCT02735083?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 28 participants. The study started on 2021-03-10. Estimated completion is 2028-09.
What conditions does trial NCT02735083 study?
This clinical trial studies the following conditions: Advanced Lymphoid Leukemia.
What interventions are being tested in trial NCT02735083?
The interventions under investigation include: UCART19 follow-up (BIOLOGICAL).
Who is sponsoring clinical trial NCT02735083?
This trial is sponsored by Institut de Recherches Internationales Servier, which has 27 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02735083 being conducted?
This trial has 16 study locations across California, Colorado, Florida, Massachusetts, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.